Latest News
From the Journals
Greening intervention tied to self-reported improved mental health
City residents reported a decrease in feelings of depression and worthlessness after vacant lots were improved.
News from the FDA/CDC
CDC reports Salmonella outbreak
Conference Coverage
Opioid crisis brings bonanza for headache research
FDA/CDC
FDA approves IDH1 inhibitor for relapsed/refractory AML
The oral medication is the first and only FDA-approved treatment for relapsed/refractory AML with an IDH1 mutation.
FDA/CDC
Essure sales to halt in U.S. by end of 2018
According to the FDA, Bayer stated its decision to halt sales and distribution of the device was because of commercial reasons.
Feature
Recommendations aim to reduce pediatric nephrology testing
“Choosing Wisely” campaign looks at kidney-related conditions.
Latest News
Respiratory illness is the most common pediatric emergency in ambulatory settings
Psychiatric and behavioral illness, seizures, and syncope were other common pediatric emergencies in ambulatory settings.
From the Journals
Phase 3 results shed light on L-glutamine use in SCD
L-glutamine is not only an alternative to hydroxyurea but an additive therapy for patients with suboptimal response, the researchers said.
Conference Coverage
Endocrinologists clash over routine CGM during pregnancy
At issue: Should diabetic women use CGM from conception through birth?